GROUP PERFORMANCE The table below shows the performance of the Group as measured by the Group’s closing share price and EPS over the last five years. 12 months ended 30 June 2022 12 months ended 30 June 2023 12 months ended 30 June 2024 12 months ended 30 June 2025 12 months ended 30 June 2026 Closing share price $0.39 $0.85 $0.56 $0.37 $0.545 Loss after tax ($) (18,195,977) (8,969,241) (6,554,350) (6,932,280) (7,505,123) EPS ($ per share) (0.2003) (0.0975) (0.0709) (0.0623) (0.0569) SHARE OPTIONS Shares issued as a result of the exercise of options During the financial year the Company issued no new ordinary shares from the exercise of options (2025: Nil). Options issued 700,000 options were issued to KMP under the terms of the IIQ Incentive Option Plan (IOP) during the financial year as follows: – 550,000 options were granted to Executives on 18 December 2025. The options are exercisable at $0.506 per option, vest in three equal tranches – 12, 24 and 36 months from grant date – and all expire on 18 December 2030. The fair value per option at grant date was calculated using a Binomial option pricing model. Options are forfeited if the Executives leave the employment of INOVIQ before vesting. There are no performance conditions attached to these options. The options were however issued at an exercise price that represented a 50% premium to IIQ’s share price at the time of issue. – 150,000 options were granted to an Executive on 12 January 2026. The options are exercisable at $0.596 per option, vest in three equal tranches – 12, 24 and 36 months from grant date – and all expire on 12 January 2030. The fair value per option at grant date was calculated using a Binomial option pricing model. Options are forfeited if the Directors leave the employment of INOVIQ before vesting. There are no performance conditions attached to these options. The options were however issued at an exercise price that represented a 50% premium to IIQ’s share price at the time of issue. In the comparative period 1,000,000 options were issued to Non Executive Directors under the terms of the IIQ Incentive Option Plan (IOP) during the financial year as follows: – Non Executive Directors (Dr Geoffrey Cumming, Max Johnston, Philip Powell and Mary Harney) were each awarded 250,000 options which were ratified at the 2024 Annual General Meeting. These options were granted on 29 November 2024. The options are exercisable at $1.00 per option, vest in three equal tranches – 12, 24 and 36 months from grant date – and all expire on 29 November 2028. The fair value per option at grant date was calculated using a Binomial option pricing model. Options are forfeited if the Directors leave the employment of INOVIQ before vesting. There are no performance conditions attached to these options. The options were however issued at an exercise price that represented a 117.39% premium to IIQ’s share price at the time of issue. Directors’ Report continued 28 INOVIQ Limited
RkJQdWJsaXNoZXIy MjE2NDg3